All Scripps Research articles
-
NewsScripps Research scientists receive $1.1 million to advance AI modeling for HIV vaccine development
Scripps Research scientists will purchase high-performance computing equipment to accelerate the identification of more effective HIV vaccine candidates through enhanced computational infrastructure, reduced data-processing bottlenecks, and state-of-the-art artificial intelligence (AI) technology.
-
NewsJie Xiao to receive 2026 Carolyn Cohen Innovation Award from The Biophysical Society
The Biophysical Society has announced that Jie Xiao, of the Johns Hopkins School of Medicine, USA, will receive the 2026 Carolyn Cohen Innovation Award.
-
NewsNIH grant aims for childhood vaccine against HIV
A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine. Source: NIAID Transmission electron micrograph ...
-
NewsResearchers map key human proteins that power coronavirus replication, pointing to new treatment strategies
Scientists have pinpointed dozens of human proteins that SARS-CoV-2 needs to complete its full life cycle, from entering a cell to replicating and releasing new viral particles.
-
NewsTiny chip speeds up antibody mapping for faster vaccine design
By analyzing just a drop of blood, this microchip gives researchers quicker-than-ever insight into how a person’s antibodies are interacting with a virus or other pathogen.
-
NewsGenomic data shows widespread mpox transmission in West Africa prior to 2022 global outbreak
Mpox was transmitted among humans in Nigeria for eight years before sparking the international outbreak in 2022. Using genomic tracing, the researchers estimate that the virus’s ancestor first emerged in southern Nigeria in August 2014.
-
NewsAntibodies that recognize lipids: A new path for HIV vaccines and autoimmune disease treatments
Scientists have used computer modeling to illustrate how a specific class of antibodies actually use lipids to recognize the HIV virus. The work highlights antibody features that could help people design better vaccines for HIV and autoimmune diseases.
-
NewsThe very first structural images of a tuberculosis-fighting virus
Scientists have used advanced imaging techniques to provide a detailed look at how a tiny virus, known as a phage, invades Mycobacteria. The research could pave the way toward phage-based treatments for antibiotic-resistant mycobacteria.
-
NewsResearchers release phage images with unprecedented detail
Researchers have produced the most detailed image to date of a bacteriophage, that has allowed them to see for the first time the structural makeup of the part of the phage that directly attaches to its target Mycobacterium cell.
-
News‘Low-sugar’ vaccine can provide broad immunity against coronavirus variants
A universal vaccine for coronaviruses removes sugar molecules from an area of a coronavirus spike protein that rarely mutates and creates effective and plentiful antibodies to inactivate the virus.
-
NewsChain reaction: HIV vaccines can lead to antibodies against antibodies
Scientists have discovered that repetitive HIV vaccinations can lead the body to produce antibodies targeting the immune complexes already bound to the virus—knowledge that could lead to better vaccines.
-
NewsResearchers use biophysics to design new vaccines against RSV and related respiratory viruses
Scientists improved existing vaccines by analyzing the molecular structure and stability of viral proteins.
-
NewsGenetic tracing at the Huanan Seafood market supports COVID animal origins
A study provides a list of the wildlife species present at the market from which SARS-CoV-2 most likely arose in late 2019, based on a new analysis of metatranscriptomic data released by the Chinese Center for Disease Control and Prevention (CDC).
-
NewsWearable health sensors are a powerful tool in disease detection
When seemingly healthy people receive an alert from a wearable sensor telling them they might have a respiratory virus, only a quarter of people follow up such an alert with an at-home viral test, according to a new study.
-
![Low-Res_Compound 7 with influenza H1 hemagglutinin_Credit Seiya Kitamura[1]](https://d3rmrttq0bsnxi.cloudfront.net/Pictures/100x67/4/1/4/7414_lowres_compound7withinfluenzah1hemagglutinin_creditseiyakitamura1_295508_crop.jpg)
NewsDrug-like inhibitor shows promise in preventing flu
Scientists have developed a potential drug-like molecule that blocks the first stage of type A influenza infection.
-
NewsAn adjuvant made in yeast could lower vaccine cost and boost availability
Scientists have wielded the power of synthetic biology to produce the active ingredient of soap bark, a molecule called QS-21, in yeast - a more environmentally friendly way to produce a key ingredient of vaccines.
-
NewsStudy reveals new approach for combatting “resting” bacteria
Blocking long phosphate molecules could eventually help treat chronic infections in which slow-growing bacteria evade typical antibiotics.
-
NewsScientists reveal how first cells could have formed on Earth
A new phospholipid discovery brings researchers closer to understanding how primordial cells emerged during origin of life.
-
NewsCalibr announces license agreement with Gilead to develop long-acting HIV antiviral agent
Long-acting combination HIV regimens have the potential to transform the future of coordinated HIV clinical care
-
NewsScientists reveal inner workings of Ebola’s ‘viral factories’
A new study reveals how the Ebola virus’s replication machinery forms fascinating microscopic structures inside host cells that become viral factories.